Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001325447-10-000005
Filing Date
2010-02-10
Accepted
2010-02-10 09:55:05
Documents
1

Document Format Files

Seq Description Document Type Size
1 abio123109g.txt SC 13G 5980
  Complete submission text file 0001325447-10-000005.txt   8188
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Subject) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-51477 | Film No.: 10586378
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 1345 AVENUE OF THE AMERICAS NEW YORK NY 10105
Business Address 1345 AVENUE OF THE AMERICAS NEW YORK NY 10105 212-698-3363
First Eagle Investment Management, LLC (Filed by) CIK: 0001325447 (see all company filings)

EIN.: 571156902 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G